S
SPARK
Biotech & Life Sciences · Seoul, South Korea · Founded 2016
Biotechnology company developing novel small-molecule therapeutics through advanced drug discovery platforms targeting cancer, neurological, and metabolic diseases. MoreLess
SPARK Biopharma, founded by Dr. Seung Bum Park in 2016, focuses on the discovery and development of small molecule therapeutics aimed at modulating the tumor microenvironment (TME) in the field of immune oncology. The company collaborates with the CRI Center for Chemical Proteomics at Seoul National University and other scientific partners to advance its drug discovery programs. SPARK Biopharma leverages proprietary technology platforms such as pDOS, Seoul Fluor, and FITGE to identify and develop novel therapeutic agents. The business primarily serves the pharmaceutical and biotechnology sectors, targeting clients interested in innovative cancer treatments. SPARK Biopharma operates within the competitive landscape of oncology drug development, generating revenue through partnerships and potential licensing agreements for its clinical candidates. The company's business model is centered around research and development, with a focus on delivering effective and targeted cancer therapies. Keywords: small molecule, therapeutics, tumor microenvironment, immune oncology, drug discovery, chemical proteomics, pDOS, Seoul Fluor, FITGE, cancer treatment.
Company overview
SPARK company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2016
- Headquarters
- Seoul, South Korea
- Employees
- 11
- Open positions
- None listed
- Dealroom signal
- 71.0
Valuation & funding
SPARK funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VCOther financing | May 2026 | $26M | $106M | Korea Development Bank · SJG Partners · Shinhan Capital · Industrial Bank of Korea | ↗ |
| SERIES COther financing | Apr 2022 | $21M | $84M | IMM Investment · Company K Partners · We Ventures · Shinhan Venture Investment | ↗ |
| SERIES BOther financing | Nov 2021 | $26M | $103M | Undisclosed | — |
| SERIES AOther financing | Jan 2021 | $6.2M | $25M | Undisclosed | — |
| SERIES AOther financing | Jul 2018 | $3.8M | $15M | Solidus Investment · KB Investment | — |
| EARLY VCOther financing | Jan 2018 | Company K Partners | ↗ | ||
| ANGELOther financing | Oct 2016 | Korea Tech Incubator Program For Startup | — | ||
| SPINOUTOther financing | Jan 2016 | Seoul National University | — |
Growth signals
SPARK website traffic
Latest recorded traffic for SPARK is 1.1K monthly website visits, up 107.5% over the last three months. SPARK's team declined 8.3% over the past year.
Comparisons
SPARK compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
SPARK's talent
Source: Dealroom Talent Intelligence.
Investors
21 investors on SPARK's cap table
Sourced from Dealroom's funding and investor records.
Global footprint
Where SPARK has talent and traffic
team presence
In the news
Latest news about SPARK
Recent press, funding announcements, and product moves mentioning SPARK — open to read from the original sources.
Market sentiment
What the market is saying about SPARK
An AI-synthesized read of the highest-engagement posts about SPARK on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See SPARK’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.